aptazapine

Uses your system voice; voice and rate in settings.

Q4782211Snapshot

≈ 2 min read

Names in other languages

  • Englishaptazapine
  • العربيةأبتازابين
  • فارسیآپتازاپین
  • shAptazapin
  • СрпскиAptazapin
  • 中文阿普氮平

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Aptazapine (developmental code name CGS-7525A) is a tetracyclic antidepressant (TeCA) that was assayed in clinical trials for the treatment of depression in the 1980s but was never marketed. It is a potent α 2 -adrenergic receptor antagonist with about 10 times the strength of the related compound mianserin and has also been shown to act as a 5-HT 2 receptor antagonist and H 1 receptor inverse agonist, while having no significant effects on the reuptake of serotonin or norepinephrine. Based on its pharmacological profile, aptazapine may be classified as a noradrenergic and specific serotonergic antidepressant (NaSSA).

Aptazapine (developmental code name CGS-7525A) is a tetracyclic antidepressant (TeCA) that was assayed in clinical trials for the treatment of depression in the 1980s but was never marketed. It is a potent α 2 -adrenergic receptor antagonist with about 10 times the strength of the related compound mianserin and has also been shown to act as a 5-HT 2 receptor antagonist and H 1 receptor inverse agonist, while having no significant effects on the reuptake of serotonin or norepinephrine. Based on its pharmacological profile, aptazapine may be classified as a noradrenergic and specific serotonergic antidepressant (NaSSA).

See also

Mianserin Mirtazapine Setiptiline

References

External links

Text derived from https://en.wikipedia.org/w/index.php?oldid=1329584248 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.